Plasma hemopexin activity in pregnancy and preeclampsia

Hypertension in Pregnancy

Volumn 26, Issue 2, 2007, Pages 227-239

  Bakker, Winston W ^a   Donker, Rogier B ^a   Timmer, Albertus ^a   Van Pampus, Mariëlle G ^a   Van Son, Willem J ^a   Aarnoudse, Jan G ^a   Van Goor, Harry ^a   Niezen Koning, Klary E ^a   Navis, Gerjan ^a   Borghuis, Theo ^a   Jongman, Rianne M ^a   Faas, Marijke M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Hemopexin; Preeclampsia; Pregnancy

Indexed keywords

ADENOSINE TRIPHOSPHATE; APYRASE; ECTO 5' NUCLEOTIDASE; HEMOPEXIN;

ARTICLE; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ACTIVITY; FASCIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PREECLAMPSIA; PREGNANCY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION;

5'-NUCLEOTIDASE; ADENOSINE TRIPHOSPHATE; ADULT; ANIMALS; ANTIGENS, CD; APYRASE; BIOLOGICAL MARKERS; BIOPSY; CAPILLARY PERMEABILITY; CASE-CONTROL STUDIES; CESAREAN SECTION; ENDOTHELIUM, VASCULAR; FASCIA; FEMALE; GLOMERULAR MESANGIUM; HEMOPEXIN; HUMANS; IMMUNOHISTOCHEMISTRY; NETHERLANDS; PLACENTAL CIRCULATION; PRE-ECLAMPSIA; PREGNANCY; RATS;

EID: 34247568356     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.1080/10641950701274896     Document Type: Article

References (32)

1. Delanghe JR, Langlois MR. Hemopexin: a review of biological aspects and the role in laboratory medicine. Clinica Chimica Acta 2001; 312:13-23.
2. Tolosano E, Altruda F. Hemopexin: Structure, function and regulation. DNA Cell Biol 2002; 21:297-306.
3. Bakker WW, Borghuis T, Harmsen MC, van den Berg A, Kema IP, Niezen KE, Kapojos JJ. Protease activity of plasma hemopexin. Kidney Int 2005; 68:603-610.
4. Cheung PK, Klok PA, Bakker WW. Minimal change-like glomerular alterations induced by a human plasma factor. Nephron 1996; 74:586-593.
5. Cheung PK, Stulp B, Immenshuh S, Borghuis T, Baller JF, Bakker WW. Is 100KF an isoform of hemopexin? Immunochemical characterization of the vasoactive plasma factor 100KF. J Am Soc Nephrol 1999; 10:1700-1708.
6. Cheung PK, Klok PA, Baller JF, Bakker WW. Induction of experimental proteinuria in vivo following infusion of human plasma hemopexin. Kidney Int 2000; 57: 1512-1520.
7. Bakker WW, van Dael ML, Pierik LJWM, van Wijk JAE, Nauta J, Borghuis T, Kapojos JJ. Altered activity of plasma hemopexin in patients with minimal change disease in relapse. Pediatr Nephrol 2005; 20:1410-1415.
8. Kapojos JJ, Poelstra K, Borghuis T, Banas B, Bakker WW. Regulation of plasma hemopexin activity by stimulated endothelial or mesangial cells. Nephron Physiol 2004; 96:1-10.
9. Davison JM. The effect of pregnancy on kidney function in renal allograft recipients. Kidney Int 1985; 27:74-79.
10. de Swiet M. The cardiovascular system in Clinical Physiology in Obstetrics (F. Hytten & G. Chamberlain, editors) second edition; Blackwell Scientific Publications London, 1980, pp 3-39.
11. W Mui KW, van Son WJ, Tiebosch ATMG, van Goor H, Bakker WW. Clinical relevance of immunohistochemical staining for ecto-AMPase and ecto-ATPase in chronic allograft nephropathy (CAN). Nephrol Dial Transplant 2003; 18:158-163.
12. Gorman MW, Marhle DR. Ogimoto K, Feigl EO. Measurement of adenine nucleotides in plasma. Luminescence 2003; 18:173-181.
13. Wachstein M, Meisel W. Histochemistry of hepatic phosphatases at a physiologic pH, with special reference to the demonstration of bile canaliculi. Am J Clin Pathol 1957; 27:13-23.
14. Baylis C, Davidson J, The urinary system in Clinical Physiology in Obstetrics. (F. Hytten & G. Chamberlain, editors), second edition, Blackwell, London, 1980, pp 245-303.
15. Agteresch HJ, Dagnelie PC, van den Berg JWO, Wilson JHP. Adenosine triphosphate; established and potential clinical applications. Drugs 1999; 58:211-232.
16. Sankaralingan S, Arenas IA, Lalu MM, Davidge ST, Preeclampsia: current understanding of the molecular basis of vascular dysfunction. Expert Rev Mol Med 2006; 8:1-20.
17. Gourine AV, Dale N, Gourine VN, Spyer KM. Fever in systematic inflammation: roles of purines. Front Biosci 2004; 9:1011-1022.
18. Freeman DJ, McManus F, Brown EA, Cherry L, Norrie J, Ramsay JE, Clark P, Walker ID, Sattar N, Greer IA. Short- and longterm changes in plasma inflammatory markers associated with preeclampsia. Hypertension 2004; 44:708-714.
19. Carrera F, Casart YC, Proverbio T, Proverbio F, Marin R. Preeclampsia and calcium-ATPase activity of plasma membranes from human myometrium and placental trophoblast. Hypertension in Pregnencay 2003; 22:295-304.
20. Brunette MG, Bastani B, Leclerc M, Narbaitz. Detection of different adenosine triphosphatases in human placental brushborder membranes. Membr Biol 1995; 145:285-293.
21. Read MA, Burra ALA, Walters WW. Vascular actions of purines in the foetal circulation of the human placenta. Br J Pharmacol 1993; 110:454-460.
22. Hou SH. The kidney in pregnancy in: Primer on Kidney Diseases. (Greenberg A. Editor) Acad. Press San Diego London sec. edition, 1998, pp 388-394.
23. Shah DM. Role of the renin-angiotensin system in the pathogenesis of preeclampsia. Am J Physiol 2005; 288:F614-F625.
24. Expression of Angiotensin II type II receptors in the systemic microvasculature of women with normal and pre-eclamptic pregnancy. J Soc Gynecol Investig 2005; 12(suppl):150A.
25. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161:1200-1204.
26. Donker RB, Molema G, Faas MM, Kallenberg CG, van Pampus MG, Timmer A, Aarnoudse JG. Absence of in vivo generalized pro-inflammatory endothelial activation in severe, early-onset preeclampsia. J Soc Gynecol Investig 2005; 12:518-528.
27. Levine RJ, Mayhard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350:672-683.
28. Clark DE, Smith KE, He Y, Day KE, Licence DR, Corps AN, Lammoglia R, Charnock-Jones DS. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod 1998; 59:1540-1548.
29. Ward PA, Cunningham TW, McCulloch KK, Johnson KJ. Regulatory effects of adenosine and adenine nucleotides on oxygen radical responses of neutrophils. Lab Invest 1988; 58:438-477.
30. Poelstra K, Baller JF, Hardonk MJ, Bakker WW. Demonstration of antithrombotic activity of glomerular adenosine diphosphatase. Blood 1991; 78:141-148.
31. Faas MM, Schuiling GA. Preeclampsia and the inflammatory response. Eur J Obstet Gynecol Reprod Biol 2001; 95:213-217.
32. Faas MM, Schuiling GA, Baller JFW, Visscher CA, Bakker, WW. A new animal model for human preeclampsia: Ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol 1994; 171:158-164.